InNexus Biotechnology, Inc.
IXSBF
$0.00
$0.000.00%
OTC PK
| 03/31/2011 | 12/31/2010 | 09/30/2010 | 06/30/2010 | 03/31/2010 | |
|---|---|---|---|---|---|
| Net Income | -563.90K | -789.80K | -937.10K | -1.86M | -1.57M |
| Total Depreciation and Amortization | 115.60K | 89.80K | 92.80K | 102.70K | 105.60K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 246.40K | 498.60K | 613.60K | 1.18M | 605.80K |
| Change in Net Operating Assets | 85.40K | 137.50K | 91.10K | 429.70K | 608.40K |
| Cash from Operations | -116.50K | -63.80K | -139.50K | -148.10K | -245.60K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | 10.90K | 3.80K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -83.90K | -- |
| Cash from Investing | -- | -- | -- | -73.00K | 3.80K |
| Total Debt Issued | 78.90K | 147.10K | 161.20K | -2.50K | 255.50K |
| Total Debt Repaid | -31.60K | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | 225.00K | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 47.90K | 145.20K | 155.10K | 216.30K | 245.50K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -68.60K | 81.40K | 15.60K | -4.80K | 3.70K |